MT-1002(Shaanxi Micot Technology)

N/A

Report date: 2024/05/22 15:21:18
NME

Base Information

Drug NameMT-1002(Shaanxi Micot Technology)
Drug Alias NameMT-1002
ClassificationSmall molecules > Synthetic peptide
Mechanisms of ActionIntegrin alpha-IIb/beta-3 antagonists
TargetsIntegrin alpha-IIb/beta-3
Therapy Area/IndicationsThrombocytopeniaBlood Coagulation DisordersThrombosis +[8] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited StatesMainland China
CombinationsNo
Global Highest StatusPhase 2 Clinical
Highest Status in ChinaPhase 2 Clinical
Originator CompaniesShaanxi Micot Pharmaceutical Technology Co Ltd
China Registration ClassClass 1 Chemical Drug in China

Develop Information

Active CompaniesShaanxi Micot Pharmaceutical Technology Co Ltd
Inactive CompaniesN/A
Active IndicationsThrombocytopeniaBlood Coagulation DisordersThrombosis +[8] 
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A